A transatlantic study, led by CRUK Manchester Institute Cancer Biomarker Centre researchers based at the city’s university, along with a team at Memorial Sloan Kettering Cancer Center in New York, could pave the way for diagnosing and characterising early stage small cell lung cancer (SCLC) using a simple blood test. Click to read more.
Doctors could one day diagnose and characterize early-stage small cell lung cancer (SCLC) with a simple blood test thanks to a transatlantic study led by CRUK Manchester Institute Cancer Biomarker Centre researchers at the University of Manchester with a team at Memorial Sloan Kettering Cancer Center in New York published in Nature Cancer.
Scientists unlock potential for small cell lung cancer blood test miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.